AbstractAutologous HIV-1-specific neutralizing antibodies (NAbs) seem unable to inhibit viral replication as they rapidly select for neutralization escape variants. However, NAbs could potentially contribute indirectly to the control of HIV-1 if changes in the viral envelope coinciding with NAb escape would impair viral replication fitness. Here we analyzed the replication kinetics of HIV-1 isolated over the course of infection from five typical progressors, three of whom developed strong autologous neutralizing humoral immunity. Viral replication rate did not correlate with viral sensitivity to autologous serum neutralization or with envelope length or number of potential N-linked glycosylation sites in gp120, suggesting that the flexibili...
Background: The rapid and continual viral escape from neutralizing antibodies is well documented in ...
Superinfection by a second human immunodeficiency virus type 1 (HIV-1) strain indicates that gaps in...
Single genome sequencing of early HIV-1 genomes provides a sensitive, dynamic assessment of virus ev...
AbstractAutologous HIV-1-specific neutralizing antibodies (NAbs) seem unable to inhibit viral replic...
Approximately 1 % of those infected with HIV-1 develop broad and potent serum cross-neutralizing ant...
Most human immunodeficiency virus type 1 (HIV-1)-infected individuals develop an HIV-specific neutra...
A substantial proportion of human immunodeficiency virus type 1 (HIV-1)-infected individuals has cro...
Antibodies that neutralize (nAbs) genetically diverse HIV-1 strains have been recovered from a subse...
AbstractAlthough the majority of primary HIV-1 variants can be neutralized by broadly neutralizing a...
Broadly neutralizing antibodies (bNAbs) have been isolated from selected HIV-1-infected individuals ...
Despite antibody-dependent cellular cytotoxicity (ADCC) responses being implicated in protection fro...
Author Summary Most HIV-1 infected individuals develop neutralizing antibodies against their own vir...
The rapid and continual viral escape from neutralizing antibodies is well documented in HIV-1 infect...
Analysis of longitudinally obtained HIV-1 env sequences from an individual with reported cross-react...
Background: The rapid and continual viral escape from neutralizing antibodies is well documented in ...
Background: The rapid and continual viral escape from neutralizing antibodies is well documented in ...
Superinfection by a second human immunodeficiency virus type 1 (HIV-1) strain indicates that gaps in...
Single genome sequencing of early HIV-1 genomes provides a sensitive, dynamic assessment of virus ev...
AbstractAutologous HIV-1-specific neutralizing antibodies (NAbs) seem unable to inhibit viral replic...
Approximately 1 % of those infected with HIV-1 develop broad and potent serum cross-neutralizing ant...
Most human immunodeficiency virus type 1 (HIV-1)-infected individuals develop an HIV-specific neutra...
A substantial proportion of human immunodeficiency virus type 1 (HIV-1)-infected individuals has cro...
Antibodies that neutralize (nAbs) genetically diverse HIV-1 strains have been recovered from a subse...
AbstractAlthough the majority of primary HIV-1 variants can be neutralized by broadly neutralizing a...
Broadly neutralizing antibodies (bNAbs) have been isolated from selected HIV-1-infected individuals ...
Despite antibody-dependent cellular cytotoxicity (ADCC) responses being implicated in protection fro...
Author Summary Most HIV-1 infected individuals develop neutralizing antibodies against their own vir...
The rapid and continual viral escape from neutralizing antibodies is well documented in HIV-1 infect...
Analysis of longitudinally obtained HIV-1 env sequences from an individual with reported cross-react...
Background: The rapid and continual viral escape from neutralizing antibodies is well documented in ...
Background: The rapid and continual viral escape from neutralizing antibodies is well documented in ...
Superinfection by a second human immunodeficiency virus type 1 (HIV-1) strain indicates that gaps in...
Single genome sequencing of early HIV-1 genomes provides a sensitive, dynamic assessment of virus ev...